Malgorzata Kluba has been a Senior Biotechnology Analyst at Candriam since 2019.
Before joining Candriam Malgorzata spent four years as an R&D scientist at ActoBio Therapeutics (Intrexon Actobiotics) in Belgium – a synthetic biology company where she had been working on novel drug delivery platform. She has also worked as a journalist for a life sciences communication agency (BioVox / Tunstone Communications), focusing on Belgian biotechnology market.
Malgorzata holds PhD degree in biochemistry and biotechnology from University of Leuven, Belgium, where she researched cancer signalling pathways.
